Global Computational Medicine and Drug Discovery Software Market Analysis and Forecast (2014-2020)

To Enquire About 

the Report Click 

Here 

IndustryARC 

Global Computational Medicine and Drug Discovery Software 

Market Analysis and Forecast (2014-2020) 

By Tools (Software, Databases and Others); By Application (Drug Discovery and 

Development, Disease Modeling, Medical Imaging and Others) & By Geography



Here 

Table of Contents 

1. Global Computational Medicine and Drug Discovery Software Market Overview 

2. Executive Summary 

3. Global Computational Medicine and Drug Discovery Software Market Landscape 

3.1. Market share Analysis 

3.2. Comparative Analysis 

3.2.1. Product Benchmarking 

3.2.2. End-User Profiling 

3.2.3. Patent Analysis 

3.2.4. Top 5 Financial Analysis 

4. Global Computational Medicine and Drug Discovery Software - Market Forces 

4.1. Market Drivers 

4.2. Market Constraints 

4.3. Market Challenges 

4.4. Attractiveness of the Industry 

4.4.1. Power of Suppliers 

4.4.2. Power of Customers 

4.4.3. Threat of New entrants 

4.4.4. Threat of Substitution 

4.4.5. Degree of Competition 

5. Global Computational Medicine and Drug Discovery Software Market – Strategic Analysis 

5.1. Value Chain Analysis 

5.2. Pricing Analysis 

5.3. Opportunity Analysis



Here 

5.4. Product Life Cycle Analysis 

5.5. Suppliers & Distributors 

6. Global Computational Medicine and Drug Discovery Software Market – By Tools 

6.1. Introduction 

6.2. Databases 

6.3. Software 

6.4. Others 

7. Global Computational Medicine and Drug Discovery Software Market – By Application 


7.2. Computational Physiological Medicine 

7.3. Drug Discovery and Development 

7.4. Medical Imaging 

7.5. Disease Modelling 

7.6. Predictive Analysis of Drug Targets 

7.7. Cellular Simulation 

7.8. Simulation Software 

7.9. Others 

8. Global Computational Medicine and Drug Discovery Software Market – By Geography 


8.2. North America 

8.2.1. U.S. 

8.2.2. Canada 

8.3. Europe 

8.3.1. U.K.



Here 

8.3.2. Germany 

8.3.3. Netherlands 

8.3.4. Norway 

8.3.5. Italy 

8.3.6. Others 

8.4. APAC 

8.4.1. China 

8.4.2. Japan 

8.4.3. Korea 

8.4.4. Australia 

8.4.5. Others 

8.5. RoW 

9. Market Entropy 

9.1. New Product Launches 

9.2. M&As, Collaborations, Partnerships & JVs 

10. Investment Opportunities 

11. Company Profiles 

11.1. Aurora Fine Chemicals LLC 

11.2. Biognos AB 

11.3. Certara, L.P. 

11.4. Chemical Computing Group Inc. 

11.5. CLC bio 

11.6. Collaborative Drug Discovery, Inc. 

11.7. Compugen Ltd.



Here 

11.8. Crown Bioscience Inc. 

11.9. Dassault Systemes, BIOVIA Corp. 

11.10. Domainex Ltd 

11.11. Entelos, Inc. 

11.12. Genedata AG 

11.13. Leadscope, Inc. 

11.14. Nimbus Therapeutics 

11.15. Prosarix Ltd 

11.16. Quant Med LLC 

11.17. Quantum Pharmaceuticals 

11.18. Rhenovia Pharma Limited 

11.19. Simulations Plus, Inc. 

11.20. Schrödinger, LLC 

12. Appendix 

12.1. Abbreviations 

12.2. Sources 

12.3. Research Methodology 

12.4. Bibliography 

12.5. Compilation of Expert Insights 

12.6. Disclaimer



Here 

LIST OF TABLES 

Table 1 Product Benchmarking for Global Computational Medicine and Drug Discovery Software 

Market – By Software ($) 

Table 2 Global Computational Medicine and Drug Discovery Software Market – Pricing Analysis 

($) 

Table 3 Global Computational Medicine and Drug Discovery Software Market Revenue, By Tools, 

2014-2020 ($M) 

Table 4 Global Computational Medicine and Drug Discovery Software Market Revenue, By 

Databases, By Application, 2014-2020 ($M) 


Databases, By Geography, 2014-2020 ($M) 


Software, By Application, 2014-2020 ($M) 


Software, By Geography, 2014-2020 ($M) 

Table 8 Global Computational Medicine and Drug Discovery Software Market Revenue, By Other 

Tools, By Application, 2014-2020 ($M) 

Table 9 Global Computational Medicine and Drug Discovery Software Market Revenue, By Other 

Tools, By Geography, 2014-2020 ($M) 


Application, 2014-2020 ($M) 

Table 11 Global Computational Medicine and Drug Discovery Software Market Revenue in 

Computational Physiological Medicine, By Tools, 2014-2020 ($M) 


Computational Physiological Medicine, By Geography, 2014-2020 ($M) 

Table 13 Global Computational Medicine and Drug Discovery Software Market Revenue in Drug 

Discovery and Development, By Tools, 2014-2020 ($M) 

Table 14 Global Computational Medicine and Drug Discovery Software Market Revenue in Drug 

Discovery and Development, By Geography, 2014-2020 ($M) 


Medical Imaging, By Tools, 2014-2020 ($M)



Here 


Medical Imaging, By Geography, 2014-2020 ($M) 


Disease Modelling, By Tools, 2014-2020 ($M) 


Disease Modelling, By Geography, 2014-2020 ($M) 


Predictive Analysis of Drug Targets, By Tools, 2014-2020 ($M) 


Predictive Analysis of Drug Targets, By Geography, 2014-2020 ($M) 


Cellular Simulation, By Tools, 2014-2020 ($M) 


Cellular Simulation, By Geography, 2014-2020 ($M) 


Simulation Software, By Tools, 2014-2020 ($M) 


Simulation Software, By Geography, 2014-2020 ($M) 

Table 25 Global Computational Medicine and Drug Discovery Software Market Revenue in Other 

Applications, By Tools, 2014-2020 ($M) 

Table 26 Global Computational Medicine and Drug Discovery Software Market Revenue in Other 

Applications, By Geography, 2014-2020 ($M) 

Table 27 Global Computational Medicine and Drug Discovery Software Market, By Geography, 


Table 28 North America: Computational Medicine and Drug Discovery Software Market Revenue, 

By Country, 2014-2020 ($M) 


By Tools, 2014-2020 ($M) 


By Application, 2014-2020 ($M) 

Table 31 Europe: Computational Medicine and Drug Discovery Software Market Revenue, By 

Country, 2014-2020 ($M)



Here 


Tools, 2014-2020 ($M) 



Table 34 APAC: Computational Medicine and Drug Discovery Software Market Revenue, By 

Country, 2014-2020 ($M) 


Tools, 2014-2020 ($M) 



Table 37 RoW: Computational Medicine and Drug Discovery Software Market Revenue, By 

Country, 2014-2020 ($M) 

Table 38 RoW: Computational Medicine and Drug Discovery Software Market Revenue, By Tools, 


Table 39 RoW: Computational Medicine and Drug Discovery Software Market Revenue, By 

Application, 2014-2020 ($M)



Here 

LIST OF FIGURES 

Figure1 Global Computational Medicine and Drug Discovery Software Market, By Geography, 

2014 - 2020 ($M) 

Figure2 Segmentation of Global Computational Medicine and Drug Discovery Software Market 

Figure3 Global Computational Medicine and Drug Discovery Software Market Competitive Share 

Analysis, 2014(%) 

Figure4 Global Computational Medicine and Drug Discovery Software Market Share, By 

Application, 2014 (%) 

Figure5 Global Computational Medicine and Drug Discovery Software Market Share, By 

Geography, 2014 (%) 

Figure6 North America Computational Medicine and Drug Discovery Software Market Share, By 

Country, 2014 (%) 

Figure7 Europe Computational Medicine and Drug Discovery Software Market Share, By Country, 

2014 (%) 

Figure8 APAC Computational Medicine and Drug Discovery Software Market Share, By Country, 


Figure9 RoW Computational Medicine and Drug Discovery Software Market Share, By Country, 


Figure10 Global Computational Medicine and Drug Discovery Software Market Recent 

Developments, By Year, 2012-2015



Here 

1. GLOBAL COMPUTATIONAL MEDICINE AND DRUG 

DISCOVERY SOFTWARE MARKET OVERVIEW 

1.1 REPORT SCOPE 

The global market for Computational Medicine and Drug Discovery Software has been segmented 

by the various tools and their applications in life sciences and healthcare. The major applications for 

global Computational Medicine and Drug Discovery Software market are found in computational 

physiological medicine, drug discovery and development, disease modeling, body simulation 

software development, predicting and analyzing specific drug targets and so on. Each of these 

segmentations has been studied to give a comprehensive analysis of the global computational 

medicine and drug discovery software market. 

The overall market has also been presented from the perspective of different geographic locations 

into standard geographic regions and key economies for this market. Competitive landscape for each 

of the capture technologies and storage methods is highlighted and the market players are profiled 

with attributes of company overview, financial overview, business strategies, product portfolio and 

recent developments. Market shares of the key players for 2014 are provided. The prominent players 

profiled in this report are Compugen Ltd., Certara, L.P., Dassault Systemes BIOVIA Corp., 

Schrödinger, LLC, Genedata AG and others. 

The report contains the most detailed and in-depth segmentation and analysis of the global 

computational medicine and drug discovery software market during the period 2014 - 2020.



Here 

1.2 Stakeholders 

The following are the prominent stakeholders in the global computational medicine and drug 

discovery software market. 

Healthcare professionals 

Chemical and Pharmaceutical experts 

IT and Software developers 

Bio-informatics professionals 

Bio-Technologists and Bio-medical engineers 

Universities and R&D institutes 

Regulatory authorities 

Patients



Here 

2. EXECUTIVE SUMMARY 

The computational medicine and drug discovery software market encompasses the use of pharmacy, 

chemistry, biotechnology and software knowledge for drug discovery and development. This is 

accompanied by development of algorithms and simulation of various models to study the 

pharmacokinetics and pharmacodynamics of a particular drug. 

The global market for computational medicine and drug discovery software is valued at $X billion in 

2014 and is projected to grow with a healthy double digit CAGR of XX% through 2020. Recent 

growth in disease modeling, drug designing and development by leveraging various bioinformatics 

tools will lead to the market growth during the period under study (2014-2020). 

SAMPLE TABLE: GLOBAL COMPUTATIONAL MEDICINE AND DRUG DISCOVERY 

SOFTWARE MARKET, BY APPLICATION, 2014-2020 ($M) 

Application 2014 2015 2016 2017 2019 2020 CAGR% 

(2015- 

2020) 

Computational 

xx xx xx xx xx xx xx% 

Physiological 

Medicine 

Drug Discovery and xx xx xx xx xx xx xx% 

Development 

Medical Imaging xx xx xx xx xx xx xx% 

Disease Modeling xx xx xx xx xx xx xx% 

Predictive Analysis xx xx xx xx xx xx xx% 

of Drug Targets 

Cellular Simulation xx xx xx xx xx xx xx% 

Simulation Software xx xx xx xx xx xx xx% 

Others xx xx xx xx xx xx xx% 

Total xx xx xx xx xx xx xx% 

Source: IndustryARC Analysis, Expert Insights 

As of 2014, the application of computational medicine in simulation of cells is estimated to grow at 

the fastest pace, due to the increasing research activities on sequencing of proteins to design and 

develop customized medicines suited to an individual’s needs. Drug discovery, development and 

disease modeling applications occupy the highest market share owing to the widespread drug 

development approaches adopted by several major pharmaceutical companies.



Here 

SAMPLE FIGURE: GLOBAL COMPUTATIONAL MEDICINE AND DRUG DISCOVERY 

SOFTWARE MARKET, BY REGION, 2014 (%) 

North America 

Europe 

APAC 

RoW 

Source: IndustryARC Analysis, Expert Insights 

The North America, led by the U.S. accounted for the largest market share in the global market for 

computational medicine and drug discovery software, occupying over 55% of the revenue in 2014. 

The huge market size can be credited to the increasing investments in R&D activities pertaining to 

drug discovery and development and disease modeling.



Here 

KEY MARKET INSIGHTS 

Disease modelling and Drug discovery applications occupied the highest market share in 

2014, in terms of applications, accounting for more than 55% of the total market revenue. 

APAC region is poised to witness the fastest market growth during the forecast period, with 

an estimated CAGR exceeding 25% owing to the increased R&D spending on 

pharmacokinetics and pharmacogenomics studies. 

The global market for computational medicine and drug discovery in 2014 is dominated by 

the databases, when segmented in terms of tools. However, the software tools are estimated 

to growth with the highest CAGR due to the growing usage in drug designing and 

modelling. 

Certara, L.P., in December, 2014 has launched “Muse Invent” in Japan, which a molecular 

design workflow that empowers researchers to design drugs with novel structures or 

scaffolds for individuals requirements. 

Schrödinger, Inc. and Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) in 

September, 2014 have signed agreements to give access to Schrödinger’s Small-Molecule 

Drug Discovery Suite and two other suites to Tri-I TDI’s researchers in order to proceed in 

preliminary research towards new therapeutics.



Here 

12.3 RESEARCH METHODOLOGY 

The quantitative and qualitative data collected for the global computational medicine and drug 

discovery market report is from a combination of secondary and primary sources. Research 

interviews were conducted with executives and/or mangers in the key device, software 

manufacturers and related organizations. These Key Opinion Leaders (KOLs) were then provided a 

questionnaire to gather quantitative and qualitative inputs on their operations, performance, 

strategies and views on the overall market, including key developments and trends. Data from 

interviews is consolidated, checked for consistency and accuracy, and the final market numbers are 

again validated by experts. The global computational medicine and drug discovery market was split 

by the tools, applications and geography based on different factors like primary and secondary 

sources, understanding of the number of companies operating in each segment and also KOL 

insights. 

We have used various secondary sources such as directories, articles, white papers, newsletters, 

annual reports and paid databases such as OneSource, Hoovers and Factiva to identify and collect 

information for extensive commercial study of the global computational medicine and drug 

discovery market. 

The approach towards finding information regarding the market and forecasting has been quite 

extensive. The key players in the market and its value chain were identified through secondary 

research and their market opinions were also gathered in a similar way through telephonic interviews 

and questionnaires. Interviews with key opinion leaders such as managers and marketing personnel 

were used extensively in understanding the need and emergence of computational medicine and 

drug discovery market. 

We also have extensive database of contacts which were used to conduct primary interviews and 

also to get their inputs using questionnaires.



Here 

THE ARC ADVANTAGE 

An analytical model lies at the core of our process, ensuring logical consistency throughout 

our research. We complement the model with secondary data and interviews with industry 

experts to reflect the latest trends. With our final expert validation, we provide you with 

only the most accurate and actionable intelligence. 

THE ARC PROCESS 

Analytical 

Method 

Base Method 

Consolidation 

Method 

Delphi 

Verification 

1. Granular 

breakdown of 

drivers into 

factors 

2. Validate all 

factors in terms 

of their present 

impact on the 

market 

3. Assign weights 

to these factors in 

terms of their 

relevance and 

impact on the 

market 

1. Get a topdown 

estimate of 

the market 

2. Follow it up 

with a bottom-up 

estimate of the 

market 

3. Check 

forconsistency 

and new growth 

factors that are 

relevant over the 

next 10 Years 

1. Granular 

breakdown of 

drivers into 

factors 

2. Validate all 

factors in terms 

of their present 

impact on the 

market. 

3. Assign weights 

to these factors in 

terms of their 

relevance and 

impact on the 

market. 

1. Verify the 

findings of the 

model with 

experts from 

across the value 

chain 

2. Verify the 

findings with 

players across 

small and large 

enterprises 

3. Tweak the 

model and add 

new factors 

4. Build the 

Analytical Model 

4. Build the Base 

model 

4. Build the 

Consolidated 

Model 

4. Finalize the 

ARC Model 

ANALYTICAL MODEL BASE MODEL CONSOLIDATED MODEL ARC MODEL



Here 

ABOUT US 

IndustryARC was started by a group of young, passionate professionals along with extensively 

experienced industry veterans across various business segments. Our focus and expertise is 

mainly in the field of analytics, market research and consulting. Our singular goal is to provide 

accurate and affordable research to our clients. 

Our research team has expertise in diverse fields like Automotive, Chemicals,Consumer 

Product & Services, Electronics, Food & Beverages, Healthcare etc., However diverse the 

expertise maybe, everyone in our team shares one common trait - we love data and we love 

providing solutions to clients using that data even more! Seeing your business flourish based 

on our solutions and strategy is what we love the most! 

IndustryARC publishes more than 30 reports on an annual basis in the mentioned Industries. 

Our reports are in-depth and high quality reports that can help decision makers frame better 

strategies for their business requirements. These reports can be further customized as per your 

needs. 

Disclaimer: 

• The reports sold by IndustryARC are limited publications containing valuable market 

information provided to a select group of customers in response to orders. 

• Our customers acknowledge and agree that any report bought from IndustryARC is for 

their own internal use and not for general publication or disclosure to third parties. 

• Our reports or part of the reports, information contained in the report, cannot be 

shared or resold to any other third party. 

• Disclosure to third parties, usage of data in a public document, article or blog by the 

customer can be done with prior permission taken from IndustryARC. 

For information regarding permissions and sales, contact: 

sales@industryarc.com | sanjay.matthews@industryarc.com



Here 

IndustryARC 

+1 614 - 588 - 8538 

sales@industryarc.com 

Copyright ©2015 IndustryARC 

All Rights Reserved. This document contains highly confidential information and is the sole 

property of IndustryARC. No part of it may be circulated, copied, quoted, or otherwise reproduced 

without the approval of IndustryARC.

Global Computational Medicine and Drug Discovery Software Market Analysis and Forecast (2014-2020)

Create successful ePaper yourself

Delete template?

Save as template?